{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T08:26:31Z","timestamp":1784795191561,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T00:00:00Z","timestamp":1503100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00259-017-3810-5","type":"journal-article","created":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T10:29:34Z","timestamp":1503138574000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["18F\u2013FDG PET\/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma"],"prefix":"10.1007","volume":"45","author":[{"given":"Domenico","family":"Albano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Bosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Treglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Giubbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,19]]},"reference":[{"key":"3810_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/j.1365-2141.2004.04834.x","volume":"124","author":"R Soutar","year":"2004","unstructured":"Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, et al. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Hematol. 2004;124:717\u201326.","journal-title":"Br J Hematol"},{"issue":"12","key":"3810_CR2","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15(12):e538\u201348.","journal-title":"Lancet Oncol"},{"issue":"6","key":"3810_CR3","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/S0889-8588(05)70124-6","volume":"13","author":"MA Dimopoulos","year":"1999","unstructured":"Dimopoulos MA, Kiamouris C, Moulopoulos LA. Solitary plasmacytoma of bone and extramedullary plasmacytoma. Hematol Oncol Clin North Am. 1999;13(6):1249\u201357.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"3810_CR4","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1182\/blood.V96.6.2037","volume":"96","author":"MA Dimopoulos","year":"2000","unstructured":"Dimopoulos MA, Moulopoulos LA, Maniatis A, Alexanian R. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood. 2000;96(6):2037.","journal-title":"Blood"},{"key":"3810_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0360-3016(89)90008-4","volume":"16","author":"DA Frassica","year":"1989","unstructured":"Frassica DA, Frassica FJ, Schray MF, Sim FH, Kyle RA. Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 1989;16:43\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3810_CR6","doi-asserted-by":"crossref","unstructured":"Dimopoulos MA, Hamilos G. Solitary bone plasmacytoma and extramedullary plasmacytoma. Curr Treat Options Oncol. 2002;3:255\u20139.","DOI":"10.1007\/s11864-002-0015-2"},{"key":"3810_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12885-016-3015-5","volume":"17","author":"N Thumallapally","year":"2017","unstructured":"Thumallapally N, Meshref A, Mousa M, Terjanian T. Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA. BMC Cancer. 2017;17:13.","journal-title":"BMC Cancer"},{"key":"3810_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ijrobp.2007.04.036","volume":"69","author":"P Lee","year":"2007","unstructured":"Lee P, Weerasuriya DK, Lavori PW, et al. Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007;69:328\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3810_CR9","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/ajh.23201","volume":"87","author":"E Warsame","year":"2012","unstructured":"Warsame E, Gertz MA, Lacy MQ, Kyle RA, Buadi F, Dingli D, et al. Trends and outcome of modern staging of solitary plasmacytoma of bone. Am J Hematol. 2012;87:647\u201351.","journal-title":"Am J Hematol"},{"key":"3810_CR10","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1002\/cncr.26031","volume":"117","author":"V Reed","year":"2011","unstructured":"Reed V, Shah J, Medeiros LJ, Ha CS, Mazloom A, Weber DM, et al. Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy. Cancer. 2011;117:4468\u201374.","journal-title":"Cancer"},{"key":"3810_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.critrevonc.2011.04.006","volume":"82","author":"C Chargari","year":"2012","unstructured":"Chargari C, Vennarini S, Servois V, Bonardel G, Lahutte M, Fourquet A, et al. Place of modern imaging modalities for solitary plasmacytoma: toward improved primary staging and treatment monitoring. Crit Rev Oncol Hematol. 2012;82:150\u20138.","journal-title":"Crit Rev Oncol Hematol"},{"key":"3810_CR12","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1200\/JCO.1993.11.7.1311","volume":"11","author":"LA Moulopoulos","year":"1993","unstructured":"Moulopoulos LA, Dimopoulos MA, Weber D, Fuller L, Libshitz HI, et al. Magnetic resonance imaging in the staging of solitary plasmacytoma of bone. J Clin Oncol. 1993;11:1311\u20135.","journal-title":"J Clin Oncol"},{"key":"3810_CR13","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U","volume":"36","author":"BG Durie","year":"1975","unstructured":"Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975;36:842\u201354.","journal-title":"Cancer"},{"key":"3810_CR14","first-page":"513","volume":"22","author":"C Nanni","year":"2008","unstructured":"Nanni C, Rubello D, Zamagni E, Castellucci P, Ambrosini V, Montini G, et al. 18F-FDG PET\/CT in myeloma with presumed solitary plasmocytoma of bone. In Vivo. 2008;22:513\u20137.","journal-title":"In Vivo"},{"key":"3810_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1089\/108497803770418382","volume":"18","author":"H Schirrmeister","year":"2003","unstructured":"Schirrmeister H, Buck AK, Bergmann L, Reske SN, Bommer M. Positron emission tomography (PET) for staging of solitary plasmacytoma. Cancer Biother Radiopharm. 2003;18:841\u20135.","journal-title":"Cancer Biother Radiopharm"},{"key":"3810_CR16","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3324\/haematol.12654","volume":"93","author":"P-Y Salaun","year":"2008","unstructured":"Salaun P-Y, Gastinne T, Frampas E, Bodet-Milin C, Moreau P, Bodere-Kraeber F. FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma. Haematologica. 2008;93:1269\u201371.","journal-title":"Haematologica"},{"key":"3810_CR17","doi-asserted-by":"publisher","first-page":"e399","DOI":"10.1097\/RLU.0000000000000819","volume":"40","author":"P Alongi","year":"2015","unstructured":"Alongi P, Zanoni L, Incerti E, Fallanca F, Mapelli P, Papathanasiou N, et al. 18F-FDG PET\/CT for early postradiotherapy assessment in solitary bone plasmacytoma. Clin Nucl Med. 2015;40:e399\u20133404.","journal-title":"Clin Nucl Med"},{"key":"3810_CR18","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1158\/1078-0432.CCR-13-2910","volume":"20","author":"G Fouquet","year":"2014","unstructured":"Fouquet G, Guidez S, Herbaux C, Van de Wyngaert Z, Bonnet S, Beauvais D, et al. Impact of initial FDG-PET\/CT and serum-free light chain on transformation of conventionally defined solitary plasmacytoma to multiple myeloma. Clin Cancer Res. 2014;20:3254\u201360.","journal-title":"Clin Cancer Res"},{"key":"3810_CR19","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ijrobp.2008.08.037","volume":"74","author":"PJ Kim","year":"2009","unstructured":"Kim PJ, Hicks RJ, Wirth A, Ryan G, Seymour JF, Prince MH, et al. Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma. Int J Radiat Oncol Biol Phys. 2009;74:740\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3810_CR20","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","volume":"18","author":"M Cavo","year":"2017","unstructured":"Cavo M, Terpos E, Nanni C, Moreau P, Lentzsch S, Zweegman S, et al. Role of 18F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the international myeloma working group. Lancet Oncol. 2017;18:e206\u201317.","journal-title":"Lancet Oncol"},{"key":"3810_CR21","doi-asserted-by":"publisher","unstructured":"Chantry A, Kazmi M, Barrington S, Goh V, Mulholland N, Streetly M, et al. Guidelines for the use of imaging in the management of patients with myeloma. Br J Hematol. 2017; https:\/\/doi.org\/10.1111\/bjh.14827 .","DOI":"10.1111\/bjh.14827"},{"issue":"2","key":"3810_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0360-3016(96)00334-3","volume":"36","author":"TW Bolek","year":"1996","unstructured":"Bolek TW, Marcus RB, Mendenhall NP. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys. 1996;36(2):329\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3810_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.anndiagpath.2015.02.006","volume":"19","author":"K Ghodke","year":"2015","unstructured":"Ghodke K, Shet T, Epari S, Sengar M, Menon H, Gujral S. A retrospective study of correlation of morphologic patterns, MIB1 proliferation index, and survival analysis in 134 cases of plasmacytoma. Ann Diagn Pathol. 2015;19:117\u201323.","journal-title":"Ann Diagn Pathol"},{"key":"3810_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0167-8140(90)90003-F","volume":"17","author":"N Mayr","year":"1990","unstructured":"Mayr N, Wen BC, Hussey DH, Burns CP, Staples JJ, Doornbos JF, et al. The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol. 1990;17:293\u2013303.","journal-title":"Radiother Oncol"},{"issue":"3","key":"3810_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0167-8140(99)00114-0","volume":"52","author":"RH Liebross","year":"1999","unstructured":"Liebross RH, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R. Clinical course of solitary extramedullary plasmacytoma. Radiother Oncol. 1999;52(3):245\u20139.","journal-title":"Radiother Oncol"},{"key":"3810_CR26","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s00277-012-1510-6","volume":"91","author":"YG Suh","year":"2012","unstructured":"Suh YG, Suh CO, Kim JS, Kim SJ, Pyun HO, Cho J. Radiotherapy for solitary plasmacytoma of bone and soft tissue. Ann Hematol. 2012;91:1785\u201393.","journal-title":"Ann Hematol"},{"key":"3810_CR27","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/1097-0142(19810801)48:3<845::AID-CNCR2820480330>3.0.CO;2-E","volume":"48","author":"R Bataille","year":"1981","unstructured":"Bataille R, Sany J. Solitary myeloma: clinical and prognostic features of a review of 114 cases. Cancer. 1981;48:845\u201351.","journal-title":"Cancer"},{"key":"3810_CR28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0360-3016(00)01572-8","volume":"50","author":"RW Tsang","year":"2001","unstructured":"Tsang RW, Gospodarowicz MK, Pintilie M, Bezjak A, Wells W, Hodgson DC, et al. Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. Int J of Radiat Oncol Biol Phys. 2001;50:113\u201320.","journal-title":"Int J of Radiat Oncol Biol Phys"},{"key":"3810_CR29","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1182\/blood-2006-04-015784","volume":"108","author":"D Dingli","year":"2006","unstructured":"Dingli D, Kyle RA, Rajkumar SV, Nowakowski GS, Larson DR, Bida JP, et al. Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood. 2006;108:1979\u201383.","journal-title":"Blood"},{"key":"3810_CR30","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1002\/cncr.10366","volume":"94","author":"RB Wilder","year":"2002","unstructured":"Wilder RB, Ha CS, Cox JD, Weber D, Delasalle K, Alexanian R. Persistence of myeloma protein for more than one year after radiotherapy is an dverse prognostic factor in solitary plasmacytoma of bone. Cancer. 2002;94:1532\u20137.","journal-title":"Cancer"},{"key":"3810_CR31","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1002\/1097-0142(19920315)69:6<1513::AID-CNCR2820690633>3.0.CO;2-X","volume":"69","author":"J Holland","year":"1992","unstructured":"Holland J, Trenkner DA, Wasserman TH, Fineberg B. Plasmacytoma. Treatment results and conversion to myeloma. Cancer. 1992;69:1513\u20137.","journal-title":"Cancer"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-017-3810-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3810-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3810-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T21:05:08Z","timestamp":1602795908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-017-3810-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,19]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["3810"],"URL":"https:\/\/doi.org\/10.1007\/s00259-017-3810-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,19]]},"assertion":[{"value":"18 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participant included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}